Doseology Sciences Inc. (DOSEF)
| Market Cap | 1.07M -71.5% |
| Revenue | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Open | 0.1300 |
| Previous Close | 0.1121 |
| Day's Range | 0.1114 - 0.1300 |
| 52-Week Range | 0.0071 - 1.8300 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Doseology Sciences
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc.... [Read more]
News
Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform
KELOWNA, BC, March 30, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD |OTCQB: DOSEF | FSE: VU70) ("Doseology" or the "Company") a consumer product innovation company focused on oral pouch an...
Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category
KELOWNA, BC, March 11, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a consumer product innovation company focused on oral stimulan...
Doseology Launches Feed That Brain® Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot
KELOWNA, BC, March 4, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") today announced the launch of the Feed That Brain® Energy Pouch...
Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors
VANCOUVER, BC, Feb. 20, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") is pleased to announce the appointment of Larry Latowsky as a ...
Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed That Brain® Enters Oral Stimulant Format
KELOWNA, BC, Jan. 21, 2026 /PRNewswire/ -- Doseology Sciences Inc. ( CSE: MOOD | PINK: DOSEF | FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today anno...
Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors
KELOWNA, BC, Jan. 16, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announ...
Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise
KELOWNA, BC, Jan. 12, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announ...
Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.
KELOWNA, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Doseology Sciences Inc. ( CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral ...
Doseology Appoints Patrick W. Sills as Strategic Go-to-Market Advisor
Kelowna, BC – July 17, 2025 – TheNewswire – Doseology Sciences Inc. ( CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants , is pl...
CSE Bulletin: Consolidation - Doseology Sciences Inc. (MOOD)
Toronto, Ontario--(Newsfile Corp. - Le 13 février/February 2024) - Doseology Sciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consol...
Doseology Announces New Director and Corporate Secretary
KELOWNA, BC , May 5, 2023 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (the "Company"), a life sciences company focused on mental health and wellness, is pleased to an...
Doseology Announces CEO Transition
KELOWNA, British Columbia, March 31, 2023 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) ("Doseology" or the "Company"), a life sciences company focused on mental healt...
Doseology Welcomes New CFO
KELOWNA, BC , March 3, 2023 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) ("Doseology" or the "Company"), a life sciences company focused on mental health and wellness,...
Doseology Provides Corporate Update
VERNON, British Columbia , Jan. 23, 2023 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) ("Doseology" or the "Company"), a life sciences company focused on mental health ...
Doseology Uplists to OTCQB Market in USA
VERNON, BC , July 6, 2022 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) ("Doseology" or the "Company"), a life sciences company focused on mental health and wellness, i...
Doseology Opens to American Investors
VERNON, BC , June 1, 2022 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (FSE: VU7) (OTC: DOSEF) ("Doseology" or the "Company"), a life sciences company focused on mental health and wellness, ...